Literature DB >> 9990326

Production of key molecules by ocular neutrophils early after herpetic infection of the cornea.

M Daheshia1, S Kanangat, B T Rouse.   

Abstract

Herpes simplex virus infection of the eye can result in a blinding inflammatory lesion that is a T cell mediated immunopathological reaction. A prominent early event following HSV infection is neutrophil invasion of the corneal stroma. These cells may be involved in viral clearance and may influence the nature of the anti HSV T cell response which subsequently occurs. This article measures the expression of some key molecules which could participate in viral clearance and immune modulation. Using RT-PCR and in-situ hybridization, both corneal and peritoneal neutrophils were shown to be sources of iNOS and TNF alpha molecules which likely contribute to antiviral activity. Neutrophils also produce the cytokine IL-12, a key molecule which modulates the CD4+ T cell response to a type which mediates immunopathology. The present results indicate that neutrophils play an important role in the pathogenesis of herpetic ocular lesions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9990326     DOI: 10.1006/exer.1998.0565

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  36 in total

1.  [Do antisense oligonucleotides improve viral immunopathology?].

Authors:  S Wasmuth; D Bauer; K P Steuhl; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

2.  Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients.

Authors:  Afsar Rahbar; Madeleine Cederarv; Nina Wolmer-Solberg; Charlotte Tammik; Giuseppe Stragliotto; Inti Peredo; Olesja Fornara; Xinling Xu; Mensur Dzabic; Chato Taher; Petra Skarman; Cecilia Söderberg-Nauclér
Journal:  Oncoimmunology       Date:  2015-08-24       Impact factor: 8.110

3.  Role of miR-155 in the pathogenesis of herpetic stromal keratitis.

Authors:  Siddheshvar Bhela; Sachin Mulik; Fernanda Gimenez; Pradeep B J Reddy; Raphael L Richardson; Siva Karthik Varanasi; Ujjaldeep Jaggi; John Xu; Patrick Y Lu; Barry T Rouse
Journal:  Am J Pathol       Date:  2015-02-18       Impact factor: 4.307

Review 4.  Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation.

Authors:  Ann-Marie Lobo; Alex M Agelidis; Deepak Shukla
Journal:  Ocul Surf       Date:  2018-10-11       Impact factor: 5.033

Review 5.  Potential function of miRNAs in herpetic stromal keratitis.

Authors:  Sachin Mulik; Siddheshvar Bhela; Barry T Rouse
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

6.  Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes.

Authors:  Dejan Milatovic; Yueli Zhang; Sandra J Olson; Kathleen S Montine; L Jackson Roberts; Jason D Morrow; Thomas J Montine; Terence S Dermody; Tibor Valyi-Nagy
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

7.  Wolbachia-induced neutrophil activation in a mouse model of ocular onchocerciasis (river blindness).

Authors:  Illona Gillette-Ferguson; Amy G Hise; Helen F McGarry; Joseph Turner; Andrew Esposito; Yan Sun; Eugenia Diaconu; Mark J Taylor; Eric Pearlman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 8.  Significance of lipid mediators in corneal injury and repair.

Authors:  Sachidananda Kenchegowda; Haydee E P Bazan
Journal:  J Lipid Res       Date:  2009-11-03       Impact factor: 5.922

9.  Influence of dimethylfumarate on experimental HSV-1 necrotizing keratitis.

Authors:  A Heiligenhaus; H Li; S Wasmuth; D Bauer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-06       Impact factor: 3.117

10.  Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis.

Authors:  Ling C Huang; Rose Y Reins; Richard L Gallo; Alison M McDermott
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.